Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions

被引:130
作者
Ferreri, Andres J. M. [1 ,2 ]
Dognini, Giuseppina P. [2 ]
Campo, Elias [3 ]
Willemze, Rein [4 ]
Seymour, John F. [5 ,6 ]
Bairey, Osnat [7 ]
Martelli, Maurizio [8 ]
De Renz, Amalia O. [9 ]
Doglioni, Claudio [10 ]
Montalban, Carlos [11 ]
Tedeschi, Alberto [12 ]
Pavlovsky, Astrid [13 ]
Morgan, Sue [14 ]
Uziel, Lilj [15 ]
Ferracci, Massimo [16 ]
Ascani, Stefano [17 ]
Gianelli, Umberto [18 ]
Patriarca, Carlo [19 ]
Facchetti, Fabio [20 ]
Dalla Libera, Alessio [21 ]
Pertoldi, Barbara [22 ]
Horvath, Barbara [23 ]
Szomor, Arpad [24 ]
Zucca, Emanuele [25 ]
Cavalli, Franco [25 ]
Ponzoni, Maurilio [10 ]
机构
[1] Ist Sci San Raffaele, Dept Oncol, Med Oncol Unit, Via Olgettina 60, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, Med Oncol Unit, Milan, Italy
[3] Hosp Clin Barcelona, Div Pathol, Barcelona, Spain
[4] Dutch Cutaneous Lymphoma Grp, Amsterdam, Netherlands
[5] Australasian Leukaemia & Lymphoma Grp, Melbourne, Vic, Australia
[6] Univ Melbourne, Melbourne, Vic, Australia
[7] Beilinson Med Ctr, Rabin Med Ctr, Div Hematol, Petah Tiqwa, Israel
[8] Univ Roma La Sapienza, Div Hematol, Rome, Italy
[9] Univ Federico II, Div Hematol, Naples, Italy
[10] Ist Sci San Raffaele, Pathol Unit, Milan, Italy
[11] Hosp Ramon & Cajal, Serv Med Interna, Madrid, Spain
[12] Osped Maggiore, Div Internal Med, Milan, Italy
[13] Fundaleu, Div Hematol, Buenos Aires, DF, Argentina
[14] Alfred Hosp, DM Hematol, Melbourne, Vic, Australia
[15] Osped San Paolo, Div Hematol, Milan, Italy
[16] Osped Belluno, Pathol Unit, Belluno, Italy
[17] Osped St Orsola, Div Pathol, Bologna, Italy
[18] Osped San Paolo, Div Pathol, Milan, Italy
[19] Osped Vizzolo Predabissi, Div Pathol, Melegnano, Italy
[20] Spedali Civili Brescia, Div Pathol, Brescia, Italy
[21] Boldrini Hosp, Neurol Div, Thiene, Italy
[22] Osped Thiene, Div Pathol, Thiene, Italy
[23] Semmelweis Univ, Dept Dermatovenereol & Dermatooncol, Budapest, Hungary
[24] Univ Pecs, Dept Med 1, Pecs, Hungary
[25] Ist Oncol Svizzera Italiana, Div Med Oncol, Bellinzona, Switzerland
关键词
intravascular lymphoma; hemophagocytosis; cutaneous lymphoma; brain lymphoma;
D O I
10.3324/haematol.10829
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives This study explored variations in the clinical manifestations of intravascular lymphoma (IVL) on the bases of the association with hemophagocytosis and the country where the diagnosis was made. Design and Methods The clinical features of 50 Western patients with IVL were compared with those of 123 patients with IVL diagnosed in Eastern countries (87 diagnosed in Japan and 36 in other Asian countries), previously reported in English literature, and collected by an electronic bibliographic search. Results Hemophagocytosis was absent in Western patients, but reported in 38 (44%) Japanese patients (p=0.00001) and in seven (19%) patients from other Asian countries (p=0.002). No clinical differences were evident between patients with hemophagocytosis-negative IVL diagnosed in Western countries, Japan and other Asian Countries. Conversely, Japanese and non-Japanese patients with hemophagocytosis-related IVL more frequently had stage IV disease, fever, hepato-splenic involvement, marrow infiltration, dyspnea, anemia, and thrombocytopenia, and rarely exhibited cutaneous or central nervous system involvement. Lymph node and peripheral blood involvement was uncommon in all subgroups. In Western patients, anthracycline-based chemotherapy was associated with a 52% remission rate, and a 2-year overall survival of 46%. Interpretation and Conclusions The clinical features of IVL vary according to the association with hemophagocytosis, regardless of the country in which the diagnosis is made. Western, Japanese and other Asian patients with hemophagocytosis-negative IVL display similar clinical characteristics and should be considered as having classical IVL. Patients with hemophagocytosis-related IVL show significantly different clinical features. Both forms have a poor prognosis. Extensive molecular studies are needed to explore whether these clinical differences might reflect discordant biological entities within IVL.
引用
收藏
页码:486 / 492
页数:7
相关论文
共 27 条
[1]  
ALHAZZAA SAF, 1993, OPHTHALMOLOGY, V100, P961
[2]   Intravascular B-cell lymphoma: Report of two cases with different clinical presentation but rapid central nervous system involvement [J].
Anghel, G ;
Pettinato, G ;
Severino, A ;
Remotti, D ;
Insabato, L ;
De Renzo, A ;
Rotoli, B ;
Majolino, I .
LEUKEMIA & LYMPHOMA, 2003, 44 (08) :1353-1359
[3]  
[Anonymous], 2001, WHO PATHOLOGY GENETI
[4]  
Chen MH, 1998, CHINESE MED J-PEKING, V111, P762
[5]   INTRAVASCULAR LYMPHOMATOSIS - A CLINICOPATHOLOGICAL STUDY OF 10 CASES AND ASSESSMENT OF RESPONSE TO CHEMOTHERAPY [J].
DIGIUSEPPE, JA ;
NELSON, WG ;
SEIFTER, EJ ;
BOITNOTT, JK ;
MANN, RB .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (12) :2573-2579
[6]   Intravascular large B-cell lymphoma with bone marrow involvement at presentation and haemophagocytic syndrome: two Western cases in favour of a specific variant [J].
Dufau, JP ;
Le Tourneau, A ;
Molina, T ;
Le Houcq, M ;
Claessens, YE ;
Rio, B ;
Delmer, A ;
Diebold, J .
HISTOPATHOLOGY, 2000, 37 (06) :509-512
[7]  
FALINI B, 1990, BLOOD, V75, P434
[8]   Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma [J].
Ferreri, AJM ;
Campo, E ;
Arnbrosetti, A ;
Ilariucci, F ;
Seymour, JF ;
Willemze, R ;
Arrigoni, G ;
Rossi, G ;
López-Guillermo, A ;
Berti, E ;
Eriksson, M ;
Federico, M ;
Cortelazzo, S ;
Govi, S ;
Frungillo, N ;
Dell'Oro, S ;
Lestani, M ;
Asioli, S ;
Pedrinis, E ;
Ungari, M ;
Motta, T ;
Rossi, R ;
Artusi, T ;
Iuzzolino, P ;
Zucca, E ;
Cavalli, F ;
Ponzoni, M .
ANNALS OF ONCOLOGY, 2004, 15 (08) :1215-1221
[9]   Intravascular lymphoma:: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant' [J].
Ferreri, AJM ;
Campo, E ;
Seymour, JF ;
Willemze, R ;
Ilariucci, F ;
Ambrosetti, A ;
Zucca, E ;
Rossi, G ;
López-Guillermo, A ;
Pavlovsky, MA ;
Geerts, ML ;
Candoni, A ;
Lestani, M ;
Asioli, S ;
Milani, M ;
Piris, MA ;
Pileri, S ;
Facchetti, F ;
Cavalli, F ;
Ponzoni, M .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (02) :173-183
[10]  
GLASS J, 1993, CANCER-AM CANCER SOC, V71, P3156, DOI 10.1002/1097-0142(19930515)71:10<3156::AID-CNCR2820711043>3.0.CO